雄牛牛乳可以通过抑制库林-3来缓解帕金森病的病理生理学
Arpitha Ashok1, H Pradeep1, H S Soundarya1
1DOS in Biotechnology, University of Mysore, Mysuru, Karnataka, India.
Bioorganic chemistry
|March 1, 2024
概括
研究人员从水牛牛奶中鉴定出一种可以抑制库林-3的,从而激活Nrf2通路. 这种在缓解帕金森症方面表现有前途.
科学领域:
- 生物化学 生化学
- 神经科学是一个神经科学.
- 分子生物学分子生物学
背景情况:
- 大奶粉/牛奶中的抗氧化具有治疗潜力.
- Nrf2通路是帕金森病 (PD) 干预的关键目标,因为它在PD中受损.
- 库林-3 E3酶是Nrf2通路的关键调节者.
研究的目的:
- 为了选水牛胆乳和牛奶的库林-3抑制.
- 为了激活Nrf2通路并减轻PD的分子病理学.
- 在C. elegans PD模型中评估已识别的的治疗潜力.
主要方法:
- 从水牛牛奶和牛奶中获得的类库的选.
- 分子建模,结合点分析和蛋白对接模拟.
- 在C. elegans中合成和体内评估氧化应激,抗氧化酶,神经化学标记物和Nrf2/Skn-1水平的类.
主要成果:
- 一种,SFVSEVPEL (≤1kDa),在库林-3抑制方面显示出最高的停靠点数 (-16.919).
- 合成的类有效地缓解了C. elegans的PD模型中的氧化病理生理学.
- 在接受治疗的C. elegans中,在行为缺陷和Nrf2/Skn-1水平上观察到显著的改善.
结论:
- 牛/牛奶可以成为PD新型治疗剂的来源.
- 通过SFVSEVPEL抑制库林-3,激活Nrf2通路,提供神经保护策略.
- 鉴定到的具有开发帕金森病新疗法的潜力.
更多相关视频
09:52Modified Roller Tube Method for Precisely Localized and Repetitive Intermittent Imaging During Long-term Culture of Brain Slices in an Enclosed System
Published on: December 28, 2017
10.7K
12:49Human Peripheral Blood Neutrophil Isolation for Interrogating the Parkinson's Associated LRRK2 Kinase Pathway by Assessing Rab10 Phosphorylation
Published on: March 21, 2020
7.5K
相关概念视频
Parkinson's Disease: Treatment
268
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
268
Parkinson's Disease: Overview
544
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
544
Neural Regulation
39.4K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.4K
Lysosomal Hydrolases
3.8K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.8K
